{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: A rat model was used to evaluate the general acute toxicity and the late cardiotoxicity of 4 mg / kg doxorubicin ( DOX ) given either as free drug or in the form of three N - ( 2 - hydroxypropyl ) methacrylamide ( HPMA ) copolymer conjugates .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| acute toxicity (general) |\n| cardiotoxicity (late) |"},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| acute toxicity (general) |\n| cardiotoxicity (late) |\n\nThe term \"toxicity\" refers to the adverse effects of a substance on living organisms. In this context, \"acute toxicity\" refers to the harmful effects of a substance that occur shortly after exposure, while \"cardiotoxicity\" refers to the harmful effects of a substance on the heart."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: A rat model was used to evaluate the general acute toxicity and the late cardiotoxicity of 4 mg / kg doxorubicin ( DOX ) given either as free drug or in the form of three N - ( 2 - hydroxypropyl ) methacrylamide ( HPMA ) copolymer conjugates .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| 4 mg / kg doxorubicin ( DOX) |\n| N - ( 2 - hydroxypropyl ) methacrylamide ( HPMA) |\n| doxorubicin |\n| HPMA copolymer conjugates |"},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| 4 mg / kg doxorubicin ( DOX) |\n| N - ( 2 - hydroxypropyl ) methacrylamide ( HPMA) |\n| doxorubicin |\n| HPMA copolymer conjugates of doxorubicin |"}
  ]
}